Pharmacist wins award for developments in rheumatology therapy
Tuesday, 26 September 2017
Rheumatology specialist pharmacist Emily Rose-Parfitt has been recognised for developing services for biologic therapy in rheumatology.
Emily was awarded the Royal Pharmaceutical Society’s Innovation in Quality Practice Award for her developments in improving the use of biologic medicines for patients with inflammatory arthritis.
Her work also involves biosimilar implementation and a new dose reduction program, ‘Biologics Treatment Reduction by Interval Management (B-TRIM)’. This best practice has been shared across the region.
Emily’s work was supported by a cost comparator tool, and the biosimilar implementation and the B-TRIM program have since made significant financial savings for the NHS.
Emily said: “Working as a non-medical prescriber in rheumatology clinics, I have the opportunity to identify issues in practice and reflect on how they could be improved. This first-hand clinical experience is invaluable in informing the finer details of the service development work to ensure implementation is practical for clinicians and appropriate for patients.
“I am fortunate to work in a proactive multidisciplinary team, with clinicians who are willing to engage in innovative changes to practice to improve outcomes for patients.”
In 2015 Emily won the national I Love My Pharmacist Award, which recognises pharmacists who go above and beyond the call of duty in the name of excellent patient care. She has showcased her work at a number of conferences and will be presenting at the Hospital Pharmacy Europe conference in November to help share best practice.
Emily has also been involved in a qualitative research study looking at patient perspectives on dose reduction, and has been invited to present a session at the British Society for Rheumatology’s conference next spring.